Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Wallace

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Physics in Medicine and Biology|September 1, 1980
Computer calculation of the dose distribution in the electron build-up regionJ M Galvin, R E Wallace, P Bloch, et al.
Cancer Research|May 1, 1979
Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in miceR E Wallace, K C Murdock, R B Angier, et al.
Medical Physics|January 1, 1995
A verification of the Monte Carlo code MCNP for thick target bremsstrahlung calculationsJ J DeMarco, T D Solberg, R E Wallace, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1995
Implications of tissue heterogeneity for radiosurgery in head and neck tumorsT D Solberg, F E Holly, A A De Salles, et al.
International Journal of Immunopharmacology|January 1, 1984
Induction of alloreactive immunosuppression by 1,4-bis [( 2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
Cancer Research|February 1, 1982
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in miceR V Citarella, R E Wallace, K C Murdock, et al.
Journal of the National Cancer Institute|October 1, 1976
Safety of viral vaccine cell substrates: a reevaluationJ C Petricciani, J B Milstien, A S Seifried, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Modulation of the immune response to tumors by a novel synthetic compound, N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763)B S Wang, V Ruszala-Mallon, R E Wallace, et al.
Journal of Lipid Research|May 1, 1995
Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humansD S Grass, U Saini, R H Felkner, et al.
Journal of Medicinal Chemistry|September 1, 1979
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesK C Murdock, R G Child, P F Fabio, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Physics in Medicine and Biology|September 1, 1980
Computer calculation of the dose distribution in the electron build-up regionJ M Galvin, R E Wallace, P Bloch, et al.
Cancer Research|May 1, 1979
Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in miceR E Wallace, K C Murdock, R B Angier, et al.
Medical Physics|January 1, 1995
A verification of the Monte Carlo code MCNP for thick target bremsstrahlung calculationsJ J DeMarco, T D Solberg, R E Wallace, et al.
International Journal of Radiation Oncology, Biology, Physics|April 30, 1995
Implications of tissue heterogeneity for radiosurgery in head and neck tumorsT D Solberg, F E Holly, A A De Salles, et al.
International Journal of Immunopharmacology|January 1, 1984
Induction of alloreactive immunosuppression by 1,4-bis [( 2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (CL 232,468)B S Wang, A L Lumanglas, V M Ruszala-Mallon, et al.
Cancer Research|February 1, 1982
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in miceR V Citarella, R E Wallace, K C Murdock, et al.
Journal of the National Cancer Institute|October 1, 1976
Safety of viral vaccine cell substrates: a reevaluationJ C Petricciani, J B Milstien, A S Seifried, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Modulation of the immune response to tumors by a novel synthetic compound, N-[4-[(4-fluorophenyl)sulfonyl]phenyl] acetamide (CL 259,763)B S Wang, V Ruszala-Mallon, R E Wallace, et al.
Journal of Lipid Research|May 1, 1995
Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humansD S Grass, U Saini, R H Felkner, et al.
Journal of Medicinal Chemistry|September 1, 1979
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesK C Murdock, R G Child, P F Fabio, et al.
Pageof 3